Nacuitys molecules are differentiated, prescription-quality, GMP-grade moieties, which, combined with innovative delivery technologies, are poised to address diseases and conditions involving oxidative stress including retinitis pigmentosa, cataract and cystinosis as well as rare neurological diseases
Supplements are not regulated by the FDA in the same way that drugs are
Additionally, it shows promise in treating neurodevelopmental disorders like autism and ADHD by enhancing synaptic plasticity and supporting cognitive and behavioral improvements
In addition, NDBs such as collagen, gelatin, dextran, agarose/alginate, hyaluronic acid, cellulose, and fibrin are also being explored in various other biomedical applications, including open incision/wound suturing, fixing, adhesion, covering, occlusion, isolation, contact inhibition, cell proliferation, tissue guiding, and controlled drug administration (Baranwal et al., 2022)